Technical Data
20 Sep 2024

Honors of our company and our cooperated partners

Download

Honors of our company and our cooperated partners

  • Passed the SFDA-China GMP audit
  • Passed the US FDA audit
  • Passed the MFDS-Korea audit
  • Passed the COFEPRIS-Mexico audit
  • Passed the EDQM-European medicine agency audit
  • Passed the EU GMP-Slovenia audit
  • Passed the ANVISA-Brasil audit
  • Passed the PMDA-Japan audit

Content provided by our supplier

Zhejiang Syntech Pharm Co., Ltd.

  • CN
  • 2024
    On CPHI since
  • 4
    Certificates
  • 1 - 24
    Employees
Company types
CMO/CDMO
Consultancy
Innovation cluster
Pharmaceutical company
Primary activities
API Producer
Cosmetic Ingredients
Intermediates Manufacturer
View company profile

Other Content from Zhejiang Syntech Pharm Co., Ltd. (1)

  • News Company focus and vision

    Our Main Products: Diabetes API and its intermediate 
    Oncology API and its intermediate
    Anti-coagulant API and its intermediate 
    Cardiovascular API and its intermediate 
    Customized Chemical Compounds 


    Our CMO Ability and Advantage:
    Four Production Workshop: Total 120+ reactors, 300m3,
    GMP Workshop(4 lines,3000m2): 100L ~ 2000L reactors & Chromatography sets.
    Multifunctional Pilot Workshop: 1 pilot lines(15 reactors), 3 sets enzyme production equipment, 3 sets hydrogenation equipment(500L-8MPa,1500L-6MPa & 3000L-5MPa)
    Multifunctional Workshop: 52 reactors (2000L-5000L) for commercial production
    Mass Production Workshop: 40 reactors, 5000L ~ 8000L
    Chemical Reaction Ability: Oxidation, Alkylation, Hydrogenation, Coupling etc.
    24 Sep 2024